GOT1 and neoplasm: To date, there has been just one investigation of TRT + NAMPT inhibitors: Elf et al. showed that the combination of 177Lu-DOTATATE and the experimental NAMPT inhibitor GMX1778 led to reduced tumor volumes and prolonged antitumor response in GOT1 tumor–bearing mice (83).